Toms Capital Investment Management LP Ambrx Biopharma Inc. Transaction History
Toms Capital Investment Management LP
- $2.54 Billion
- Q3 2024
A detailed history of Toms Capital Investment Management LP transactions in Ambrx Biopharma Inc. stock. As of the latest transaction made, Toms Capital Investment Management LP holds 1,000,000 shares of AMAM stock, worth $28 Million. This represents 0.66% of its overall portfolio holdings.
Number of Shares
1,000,000Holding current value
$28 Million% of portfolio
0.66%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding AMAM
# of Institutions
2Shares Held
31.2KCall Options Held
0Put Options Held
0About Ambrx Biopharma Inc.
- Ticker AMAM
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,618,400
- Market Cap $1.08B
- Description
- Ambrx Biopharma Inc., a clinical-stage biologics company, discovers and develops engineered precision biologics using its proprietary expanded genetic code technology platform. Its lead product candidate is ARX788, an anti-HER2 antibody-drug conjugate (ADC), which is investigated in various clinical trials for the treatment of breast cancer, gas...